Evidence map›Paper›PMID 34286830›Full record

ArticleClinical chemistry2021

SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing.

Sanjay Srivatsan, Sarah Heidl, Brian Pfau, Beth K Martin, Peter D Han, Weizhi Zhong, Katrina van Raay, Evan McDermot, Jordan Opsahl, Luis Gamboa and 26 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022-2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Critical evaluation of strategies to achieve direct real-time PCR detection of swine pathogens in oral fluids.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2023
    Article
  10. Article
  11. Article
  12. Dry Swab-Based Nucleic Acid Extraction vs. Spin Column-Based Nucleic Acid Extraction for COVID-19 RT-PCR Testing: A Comparative Study.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors at 4 institutions in 1 country.

Sanjay SrivatsanDepartment of Genome Sciences, University of Washington, Seattle, WA.
Sarah HeidlDepartment of Genome Sciences, University of Washington, Seattle, WA.
Brian PfauDepartment of Genome Sciences, University of Washington, Seattle, WA.
Beth K MartinDepartment of Genome Sciences, University of Washington, Seattle, WA.
Peter D HanBrotman Baty Institute for Precision Medicine, Seattle, WA.
Weizhi ZhongBrotman Baty Institute for Precision Medicine, Seattle, WA.
Katrina van RaayBrotman Baty Institute for Precision Medicine, Seattle, WA.
Evan McDermotBrotman Baty Institute for Precision Medicine, Seattle, WA.
Jordan OpsahlBrotman Baty Institute for Precision Medicine, Seattle, WA.
Luis GamboaBrotman Baty Institute for Precision Medicine, Seattle, WA.
Nahum SmithBrotman Baty Institute for Precision Medicine, Seattle, WA.
Melissa TruongBrotman Baty Institute for Precision Medicine, Seattle, WA.
Shari ChoBrotman Baty Institute for Precision Medicine, Seattle, WA.
Kaitlyn A BarrowCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Lucille M RichCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Jeremy StoneBrotman Baty Institute for Precision Medicine, Seattle, WA.
Caitlin R WolfDepartment of Allergy and Infectious Disease, University of Washington, Seattle, WA.
Denise J McCullochDepartment of Allergy and Infectious Disease, University of Washington, Seattle, WA.
Ashley E KimDepartment of Allergy and Infectious Disease, University of Washington, Seattle, WA.
Elisabeth BrandstetterBrotman Baty Institute for Precision Medicine, Seattle, WA.ORCID 0000-0003-0521-4131
Sarah L SohlbergDepartment of Allergy and Infectious Disease, University of Washington, Seattle, WA.
Misja IlcisinVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Rachel E GeyerDepartment of Family Medicine, University of Washington, Seattle, WA.
Wei ChenDepartment of Genome Sciences, University of Washington, Seattle, WA.
Jase GehringDepartment of Genome Sciences, University of Washington, Seattle, WA.
Seattle Flu Study Investigators
Sriram KosuriOctant, Inc. Emeryville, CA.
Trevor BedfordDepartment of Genome Sciences, University of Washington, Seattle, WA.
Mark J RiederBrotman Baty Institute for Precision Medicine, Seattle, WA.
Deborah A NickersonDepartment of Genome Sciences, University of Washington, Seattle, WA.
Helen Y ChuBrotman Baty Institute for Precision Medicine, Seattle, WA.
Eric Q KonnickBrotman Baty Institute for Precision Medicine, Seattle, WA.
Jason S DebleyCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0001-6438-9535
Jay ShendureDepartment of Genome Sciences, University of Washington, Seattle, WA.
Christina M LockwoodDepartment of Genome Sciences, University of Washington, Seattle, WA.
Lea M StaritaDepartment of Genome Sciences, University of Washington, Seattle, WA.ORCID 0000-0003-2870-5099
University of Washington · USBrotman Baty Institute · USHoward Hughes Medical Institute · USInfectious Disease Research Institute · US

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Impact of Heterogeneous Airway Epithelial ACE2 Expression and Interferon Responses on SARS-CoV2 Infectivity and ReplicationK24AI150991 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI DEBLEY, JASON S · 2020 to 2024
$1.2M
Bill and Melinda Gates FoundationBrotman Baty Institute for Precision MedicineEllume and Cepheid outside of the submitted workEmergent Ventures 1RM1HG010461-01Gates VenturesGinkgo Bioworks supporting separate work on CLIA laboratory formationHAARVI study comes from DARPA HR001117S0019Howard Hughes Medical InstituteNHGRINHGRI NIH HHS RM1 HG010461NIAID NIH HHS K24 AI150991NIAID NIH HHS T32 AI007044NIGMS NIH HHS T32 GM007266NIH/NIAID K24AI150991-01S1Sanofi PasteurSecurity Act (CARES Act)Testing for America supporting separate work on SwabSeq developmentThe Seattle Flu Study and SCANUniversity of Washington
6 · The paper itself

Abstract

backgroundThe urgent need for massively scaled clinical testing for SARS-CoV-2, along with global shortages of critical reagents and supplies, has necessitated development of streamlined laboratory testing protocols. Conventional nucleic acid testing for SARS-CoV-2 involves collection of a clinical specimen with a nasopharyngeal swab in transport medium, nucleic acid extraction, and quantitative reverse-transcription PCR (RT-qPCR). As testing has scaled across the world, the global supply chain has buckled, rendering testing reagents and materials scarce. To address shortages, we developed SwabExpress, an end-to-end protocol developed to employ mass produced anterior nares swabs and bypass the requirement for transport media and nucleic acid extraction.

methodsWe evaluated anterior nares swabs, transported dry and eluted in low-TE buffer as a direct-to-RT-qPCR alternative to extraction-dependent viral transport media. We validated our protocol of using heat treatment for viral inactivation and added a proteinase K digestion step to reduce amplification interference. We tested this protocol across archived and prospectively collected swab specimens to fine-tune test performance.

resultsAfter optimization, SwabExpress has a low limit of detection at 2-4 molecules/µL, 100% sensitivity, and 99.4% specificity when compared side by side with a traditional RT-qPCR protocol employing extraction. On real-world specimens, SwabExpress outperforms an automated extraction system while simultaneously reducing cost and hands-on time.

conclusionSwabExpress is a simplified workflow that facilitates scaled testing for COVID-19 without sacrificing test performance. It may serve as a template for the simplification of PCR-based clinical laboratory tests, particularly in times of critical shortages during pandemics.

Indexed as

COVID-19Clinical Laboratory TechniquesCOVID-19 Nucleic Acid TestingHumansReal-Time Polymerase Chain ReactionRNA, ViralSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingRNA, Viral

Identifiers

PMID34286830
PMCPMC8406859
OpenAlexW3183773717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.